A study shows that patients with HCV cirrhosis treated with oral direct-acting antiviral agents were not at increased risk for developing HCC. However, recent conflicting data suggest a possible association between HCC risk and antiviral therapy.
Learn more here: bit.ly/2fWDyEf
